首页 > 市场调查报告书 > 製药

个人化医学

市场调查报告书

商品编码

1461340

精准医疗市场，按应用、按技术、按最终用户、地理位置

Precision Medicine Market, By Application, By Technology, By End User, By Geography

出版日期: 2024年03月19日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年精准医疗市场价值为923.1亿美元，预计到2031年将达到1952.2亿美元，2024年至2031年的年复合成长率（CAGR）为11.3%。

报告范围		报告详情
基准年：	2023年	2023/2024 年市场规模：	923.1 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测期间 2023/2024 至 2030/2031 年复合成长率：	11.30%	2030/2031 价值预测：	1952.2 亿美元

精准医疗市场占有率 (%)（按地区），2024 年

精准医学是一种新兴的疾病治疗和预防方法，它考虑了每个人基因、环境和生活方式的个体差异。这种方法使医生和研究人员能够更准确地预测特定疾病的哪些治疗和预防策略将在哪些人群中发挥作用。它与一刀切的方法形成鲜明对比，在这种方法中，疾病治疗是适用于所有人的标准化方法。精准医学将遗传讯息和分子诊断结合起来，根据每个患者的个别特征制定医疗治疗方案。随着对患者基因组成的更多了解，医生可以确定某些药物、生活方式的改变或治疗是否有帮助，或者是否需要根据个人情况考虑不同的选择。这使得研究人员和医疗保健提供者能够确定为每位患者量身定制的最安全的治疗方案，从而改善治疗结果。透过持续的研究和开发，精准医学有望透过有针对性的疾病预防和治疗来改变医疗保健。

市场动态：

全球精准医疗市场的推动因素包括个人化医疗需求的不断增长、精准疗法开发研发投资的增加、下一代定序（NGS）在精准医疗中的应用不断增长以及医疗保健减少需求的激增。然而，缺乏资料解释和标准化以及治疗成本高昂预计将限制市场成长。同时，新兴经济体为市场参与者提供了高成长的机会。与传统治疗方法相比，精准医学方法可以透过提供具有更高疗效和减少副作用的标靶治疗来帮助解决一些新兴的医疗保健挑战。伴随诊断的日益普及以及精准医学在药物开发活动中的应用也带来了新的机会。

研究的主要特点：

该报告对全球精准医疗市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数描述了全球精准医疗市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球精准医疗市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和金融分析师。
利害关係人可以透过用于分析全球精准医疗市场的各种策略矩阵轻鬆做出决策。

介绍
2024 年及 2031 年按地区分類的市占率分析 (%)
各地区较去年同期成长分析
区域趋势
北美洲
我们
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
东协
澳洲
韩国
亚太地区其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
北非
中非
南非

第 8 章：竞争格局

Intomics
GENinCode
NanoString
Tepnel Pharma Services Limited
Pfizer Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc
QIAGEN
Quest Diagnostics Incorporated
Medtronic
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
bioMerieux SA
F. Hoffmann-La Roche Ltd
Eli Lilly & Company
GlaxoSmithKline plc
Cepheid
AstraZeneca PLC
Myriad Genetics, Inc.
Bristol-Myers Squibb Company

第 9 章：分析师观点

命运之轮
分析师观点
连贯的机会图

第 10 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI145

The precision medicine market is estimated to be valued at USD 92.31 Bn in 2024 and is expected to reach USD 195.22 Bn by 2031, growing at a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 92.31 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	11.30%	2030/2031 Value Projection:	US$ 195.22 Bn

Precision Medicine Market Share (%), By Region, 2024

Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. This approach allows doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a one-size-fits-all approach, where disease treatment is a standardized approach for all people. Precision medicine integrates genetic information and molecular diagnostics to tailor medical treatments based on the individual characteristics of each patient. With greater knowledge of patients' genetic makeup, doctors can determine if certain medicines, lifestyle changes, or treatments will help or if different options may need to be considered depending on the individual. This allows researchers and healthcare providers to determine the safest treatment option tailored for each patient, leading to improved treatment outcomes. With continued research and development, precision medicine holds promise to transform healthcare through targeted disease prevention and treatment.

Market Dynamics:

The global precision medicine market is driven by the increasing demand for personalized healthcare, rise in R&D investments for precision therapeutics development, growing application of next-generation sequencing (NGS) in precision medicine, and surging demand for healthcare reduction. However, the lack of data interpretation & standardization and high cost of treatment are expected to restrain the market growth. Meanwhile, emerging economies offer high-growth opportunities for market players. Precision medicine approaches could help address several burgeoning healthcare challenges by offering targeted therapeutics with improved efficacy and reduced side-effects compared to conventional treatment methods. The growing adoption of companion diagnostics and inclusion of precision medicine in drug development activities also presents new opportunities.

Key Features of the Study:

This report provides an in-depth analysis of the global precision medicine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global precision medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMerieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics Inc., and Bristol-Myers Squibb Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global precision medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global precision medicine market.

Market Segmentation

Technology:
- Bioinformatics
- Gene Sequencing
- Precision Molecular Diagnostics
- Big Data Analytics
- Others
Application:
- Oncology
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
- Central Nervous System
- Hematology
- Immunology
- Respiratory
- Others
End User:
- Biopharmaceutical Companies
- Diagnostic Laboratories
- Academic & Research Institutions
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Intomics
- GENinCode
- NanoString
- Tepnel Pharma Services Limited
- Pfizer Inc.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Merck & Co. Inc
- QIAGEN
- Quest Diagnostics Incorporated
- Medtronic
- Thermo Fisher Scientific Inc.
- Laboratory Corporation of America Holdings
- bioMerieux SA
- Hoffmann-La Roche Ltd
- Eli Lilly & Company
- GlaxoSmithKline plc
- Cepheid
- AstraZeneca PLC
- Myriad Genetics Inc.
- Bristol-Myers Squibb Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Acquisitions and Partnerships Scenario
Ongoing Developments
Porter's Analysis
PEST Analysis

4. Global Precision Medicine Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Precision Medicine Market, By Technology, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Bioinformatics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Gene Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Precision Molecular Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Big Data Analytics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

6. Global Precision Medicine Market, By Application, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Others
Central Nervous System
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Hematology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Immunology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Respiratory
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

7. Global Precision Medicine Market, By Region, 2019 - 2031, (US$ Billion)

Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Regions, 2019-2031
Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
UK
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (US$ Billion)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Intomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GENinCode
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NanoString
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Tepnel Pharma Services Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co., Inc
QIAGEN
Quest Diagnostics Incorporated
Medtronic
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
bioMerieux SA
F. Hoffmann-La Roche Ltd
Eli Lilly & Company
GlaxoSmithKline plc
Cepheid
AstraZeneca PLC
Myriad Genetics, Inc.
Bristol-Myers Squibb Company